Skip to main content

CIRM Publications

CIRM Publications

Strategic Plans

Scientific Strategic Plan (October 2009) [pdf]
Scientific Strategic Plan (December 2006) [pdf]

Annual Reports

Commissioned Reports

Coverage, Cost-Control Mechanisms, and Financial Risk-Sharing Alternatives of High-Cost Health Care Technologies [pdf]
Supporting Diversity in Research Participation: A Framework for Action [pdf]
Economic Impact of Research Funded by the California Institute for Regenerative Medicine [pdf]

Publications by CIRM Staff

Adams A, Lomax G, Sanatarini A (2011) Social media and stem cell science: examining the discourse. Regen Med. 6(6SuppL.):121-124.
Grieshammer U, Shepard KA, Nigh A,Trounson AO (2011) Finding the niche for human somatic cell nuclear transfer. Nature Biotech 2011 Aug 5;29(8):701-5.
Lomax, G.P., Peckman, S.R. (2011) Stem Cell Policy Exceptionalism: Proceed with Caution. Stem Cell Reviews and Reports. Vol. 5, No. 1.
Robson J, Trounson A (2011) The potential of stem cells for 21st century neuroscience. Special Issue: Stem Cells in Neuroscience. Neurochem Int. Sep;59(3):327-8.
Trounson A (2011) CIRM the way ahead. Regen Med. May;6(3):285-90.
Trounson A, Baum E (2011) Regulatory Challenges – The Survey Says. EBR (in press)
Trounson A, DeWitt N, Feigal EG (2011) A New Model Needed for the Delivery of Stem Cell Therapies in Translation for Regenerative Medicine – The Alpha Stem Cell Clinic. Stem Cells Translation Med (in press)
Trounson A, Thaker R, Lomax G, Gibbons D (2011) Clinical trials for stem cell therapies. BMC Med. 2011 May 10;9(1):52.
Carson S, Eschenbach D, Lomax G, Rice V, Sauer M, Taylor R (2010) Proposed oocyte donation guidelines for stem cell research. ASRM Fertility and Sterility. Vol 94, No7.
Klein R N , Trounson A (2010) A new political-financial paradigm for medical research: the California model. . In C. Prescott and I Polak, eds., The Delivery of Regenerative Medicines and Their Impact on Healthcare. London: Taylor & Francis Group, LLC pp 11-33.
Lomax, G.P. (2010) Stem Cell Research: A Platform for Science-Policy Innovation. Stanford Journal of Law, Science and Policy. March 2010
Lomax, G.P. (2010) Rejuvenated Federalism: State-Based Stem Cell Research Policy. In Contested Cells: Global Perspectives on the Stem Cell Debate: Capps B.J., Campbell A.V.editors.
Trounson A, Baum E, Gibbons D, Tekamp-Olson P (2010) Developing a model for successful translation of stem cell therapies. Cell Stem Cell 6(6):513-6.
Martell K, Trounson A, Baum E (2010) Stem cell therapies in clinical trials: Workshop on best practices and the need for harmonization. Cell Stem Cell 7(4):451-4
Tekamp-Olson P, Canet-Aviles, Collins L R, Steffen B J, Talib S, Trounson A (2010) Challenges in taking embryonic stem cells from bench to clinic. In: Stem Cells From Bench to Bedside (Second Edn) A Bongso, E H Lee eds.
Trounson A.(2010) Law, Ethics, Religion, and Clinical Translation in the 21st Century. Stem Cells. Jan 8;28(1):2.
Trounson A (2009) Rats, Cats, and elephants, but still no unicorn: Induced pluripotent stem cells from new species. Cell Stem Cell. Jan 9;4(1):3-4.
Trounson A (2009) New perspectives in human stem cell therapeutic research. BMC Med. 2009 Jun 11;7:29-33.
Lomax, G.P., McNab, A. (2008) Harmonizing Standards and Coding for hESC Research. Cell Stem Cell 2, March.
Lomax, G.P., Stayn S., (2008) Similarities and Differences Among Stem Cell Research Policies: Opportunities for Policymakers, Patients, and Researchers. Medical Research Law and Policy.11-5-08.
Trounson A. (2008) Integration and translation: driving stem cell therapies toward the clinic. Regen Med. May;3(3):269-73.
Trounson A, Klein R, Murphy R (2008) Stem cell research in California: the game is on. Cell Feb 22;132(4):522-4.
Lomax, G.P., Hall, Z.W., Lo B. (2007) Responsible Oversight of Human Stem Cell Research: The California Institute for Regenerative Medicine’s Medical and Ethical Standards. PLOS Medicine May 2007, Volume 4. Issue 5 e114.